Optimization of Imidazo[4,5-b]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia

[Image: see text] Optimization of the imidazo[4,5-b]pyridine-based series of Aurora kinase inhibitors led to the identification of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine (27e), a potent inhibitor of Aurora kinases (Aurora-A K(d) = 7.5...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bavetsias, Vassilios, Crumpler, Simon, Sun, Chongbo, Avery, Sian, Atrash, Butrus, Faisal, Amir, Moore, Andrew S., Kosmopoulou, Magda, Brown, Nathan, Sheldrake, Peter W., Bush, Katherine, Henley, Alan, Box, Gary, Valenti, Melanie, de Haven Brandon, Alexis, Raynaud, Florence I., Workman, Paul, Eccles, Suzanne A., Bayliss, Richard, Linardopoulos, Spiros, Blagg, Julian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Chemical Society 2012
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3483018/
https://ncbi.nlm.nih.gov/pubmed/23043539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm300952s
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items